Diasend Strengthens Partnership With DexCom To Seamlessly Sync Mobile Continuous Glucose Meter (CGM) Data For Patients And Healthcare Providers On The Go
STOCKHOLM, September 14, 2015 /PRNewswire/ --
Diasend, the global leader in diabetes connectivity, today announced that mobile CGM (Continuous Glucose Monitoring) data from the Dexcom G5® Mobile[1] will seamlessly be integrated in diasend®. Patients using diasend® will now have the ability to automatically combine their mobile CGM data with their insulin pump and activity data. All data will be securely stored and easily accessible in one place. Patients may easily share their data, making it readily available for their healthcare provider.
(Logo: http://photos.prnewswire.com/prnh/20150914/266065LOGO )
"We are excited to be partnering with Diasend to bring relevant and meaningful solutions to diabetes management. The intensive nature of diabetes data commands smart software that can interpret information into actionable decisions. Together with Diasend, we are committed to bringing these solutions to fruition," said Kevin Sayer, CEO of Dexcom, Inc.
This opens up new opportunities for healthcare providers to remotely monitor their patients, and offers more efficient workflow for clinics. CGM data can now be imported to diasend® without any cables, which saves time for both the patient and the provider.
"We have seen a remarkable progress in diabetes data management during the 10 years Diasend has been on the market. The next step for Diasend is to be more involved in patient care and thereby improve the support for healthcare providers," said Anders Sonesson, CEO and founder of Diasend.
Mobile CGM data will integrate via the diasend® Connected Apps™ feature that was launched in 2014. So far, it has been used for syncing activity data from apps such as Fitbit and Jawbone. Dexcom G5 Mobile is the first mobile CGM app to become integrated with diasend®, and more solutions and device compatibility are under development. Dexcom G5 Mobile will be available in pre-determined markets, and will be compatible with diasend® at launch. Like the previous products from Dexcom the new Dexcom G5® Mobile receiver will also be compatible for traditional uploads with diasend®.
Diasend is also happy to announce that its new mobile app is now available. With the diasend® Mobile app, patients can monitor their diabetes data, share their progress and even upload glucose data on the go. Both diasend® Connected Apps™ and the diasend® Mobile app will be demonstrated at the European Association for the Study of Diabetes (EASD) conference in Stockholm 2015.
1. Dexcom G5 Mobile is the first mobile connected CGM system on the market.
About Diabetes:
Today, over 382 million people are living with diabetes worldwide. It is estimated that 592 million people will be living with diabetes in 2035, an increase of 55 percent, which equals to about one in ten, according to the International Diabetes Federation (IDF). According to the IDF Diabetes Atlas, 548 billion USD were spent on diabetes in 2013.
About CGM:
Continuous glucose monitoring (CGM) systems provide real-time glucose readings. This allows people with diabetes, their family members and healthcare providers to see glucose levels and track how quickly they are increasing or decreasing.
About Diasend:
Diasend AB, headquartered in Gothenburg (Sweden) with offices in Chicago (USA) and London (United Kingdom), is a global company seeking to simplify life for people with diabetes and facilitate every day work for healthcare providers by streamlining communication. Today, diasend® is available in 17 countries and 14 languages. The solution is compatible with more than 130 types of glucose meters, insulin pumps, CGM systems and activity trackers. With the new mobile app, patients can monitor their information on the go and share their progress with family and friends. The diasend® solution has FDA clearance and is CE marked. For more information, please visit http://www.diasend.com.
About Dexcom:
Dexcom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) products and tools for adult and pediatric patients. With exceptional performance, patient comfort and lifestyle flexibility at the heart of its technology, users have consistently ranked Dexcom highest in customer satisfaction and loyalty. For more information on the Dexcom CGM, visit http://www.dexcom.com.
Contact:
Anders Sonesson (CEO, Diasend AB)
anders.sonesson@diasend.com | +46-735-45-88-88
SOURCE Diasend
Help employers find you! Check out all the jobs and post your resume.
Diasend, the global leader in diabetes connectivity, today announced that mobile CGM (Continuous Glucose Monitoring) data from the Dexcom G5® Mobile[1] will seamlessly be integrated in diasend®. Patients using diasend® will now have the ability to automatically combine their mobile CGM data with their insulin pump and activity data. All data will be securely stored and easily accessible in one place. Patients may easily share their data, making it readily available for their healthcare provider.
(Logo: http://photos.prnewswire.com/prnh/20150914/266065LOGO )
"We are excited to be partnering with Diasend to bring relevant and meaningful solutions to diabetes management. The intensive nature of diabetes data commands smart software that can interpret information into actionable decisions. Together with Diasend, we are committed to bringing these solutions to fruition," said Kevin Sayer, CEO of Dexcom, Inc.
This opens up new opportunities for healthcare providers to remotely monitor their patients, and offers more efficient workflow for clinics. CGM data can now be imported to diasend® without any cables, which saves time for both the patient and the provider.
"We have seen a remarkable progress in diabetes data management during the 10 years Diasend has been on the market. The next step for Diasend is to be more involved in patient care and thereby improve the support for healthcare providers," said Anders Sonesson, CEO and founder of Diasend.
Mobile CGM data will integrate via the diasend® Connected Apps™ feature that was launched in 2014. So far, it has been used for syncing activity data from apps such as Fitbit and Jawbone. Dexcom G5 Mobile is the first mobile CGM app to become integrated with diasend®, and more solutions and device compatibility are under development. Dexcom G5 Mobile will be available in pre-determined markets, and will be compatible with diasend® at launch. Like the previous products from Dexcom the new Dexcom G5® Mobile receiver will also be compatible for traditional uploads with diasend®.
Diasend is also happy to announce that its new mobile app is now available. With the diasend® Mobile app, patients can monitor their diabetes data, share their progress and even upload glucose data on the go. Both diasend® Connected Apps™ and the diasend® Mobile app will be demonstrated at the European Association for the Study of Diabetes (EASD) conference in Stockholm 2015.
1. Dexcom G5 Mobile is the first mobile connected CGM system on the market.
About Diabetes:
Today, over 382 million people are living with diabetes worldwide. It is estimated that 592 million people will be living with diabetes in 2035, an increase of 55 percent, which equals to about one in ten, according to the International Diabetes Federation (IDF). According to the IDF Diabetes Atlas, 548 billion USD were spent on diabetes in 2013.
About CGM:
Continuous glucose monitoring (CGM) systems provide real-time glucose readings. This allows people with diabetes, their family members and healthcare providers to see glucose levels and track how quickly they are increasing or decreasing.
About Diasend:
Diasend AB, headquartered in Gothenburg (Sweden) with offices in Chicago (USA) and London (United Kingdom), is a global company seeking to simplify life for people with diabetes and facilitate every day work for healthcare providers by streamlining communication. Today, diasend® is available in 17 countries and 14 languages. The solution is compatible with more than 130 types of glucose meters, insulin pumps, CGM systems and activity trackers. With the new mobile app, patients can monitor their information on the go and share their progress with family and friends. The diasend® solution has FDA clearance and is CE marked. For more information, please visit http://www.diasend.com.
About Dexcom:
Dexcom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) products and tools for adult and pediatric patients. With exceptional performance, patient comfort and lifestyle flexibility at the heart of its technology, users have consistently ranked Dexcom highest in customer satisfaction and loyalty. For more information on the Dexcom CGM, visit http://www.dexcom.com.
Contact:
Anders Sonesson (CEO, Diasend AB)
anders.sonesson@diasend.com | +46-735-45-88-88
SOURCE Diasend
Help employers find you! Check out all the jobs and post your resume.